Skip to content
NewsBlazeAU – Lifestyle
Author:
Applied Biologics
Applied Biologics Welcomes CMS’ Continued Commitment to Clinical Evidence in Advanced Wound Care
August 19, 2026
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
August 18, 2026
Applied Biologics Launches National Health System Partnership Initiative
August 12, 2026
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway
August 10, 2026
Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial
August 5, 2026
Applied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process
August 4, 2026
Applied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™
July 30, 2026
Applied Biologics Expands National Commercial Payer Engagement Strategy for XWRAP®
July 28, 2026
Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®
July 27, 2026
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
July 21, 2026
1
2
3
Next Page
→